Immunology-focused Windward Bio raised a mega-round of financing to help a lead program in growth for respiratory issues and a second program that might discover use in respiratory and dermatological indications. Each medication are long-acting antibodies that provide a dosing edge over presently obtainable biologic medicines.
The put up Windward Bio Secures $165M for Scientific Trials in Bronchial asthma, COPD & Extra appeared first on MedCity Information.
